Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults | Zendy

Christine Danel | Zendy; Raoul Moh | Zendy; MarieLaure Chaix | Zendy; Delphine Gabillard | Zendy; Joachim Gnokoro | Zendy; Charles-Joseph Diby | Zendy; Thomas d’Aquin Toni | Zendy; Lambert Dohoun | Zendy; Christine Rouzioux | Zendy; E. Bissagnéné | Zendy; Roger Salamon | Zendy; Xavier Anglaret | Zendy

Open Access

Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults

Author(s) -

Christine Danel,

Raoul Moh,

MarieLaure Chaix,

Delphine Gabillard,

Joachim Gnokoro,

Charles-Joseph Diby,

Thomas d’Aquin Toni,

Lambert Dohoun,

Christine Rouzioux,

E. Bissagnéné,

Roger Salamon,

Xavier Anglaret

Publication year - 2008

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/595298

Subject(s) - regimen , antiretroviral therapy , randomized controlled trial , medicine , human immunodeficiency virus (hiv) , pediatrics , viral load , family medicine

A randomized trial was launched in Côte d'Ivoire in 2002 to compare continuous antiretroviral treatment (hereafter, "C-ART") to an ART regimen of 2 months off and 4 months on therapy (hereafter, "2/4-ART"). We report the final analysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research